INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING

Maid Pablo; Real Rosa; Pedersen Ron; Shen Qi; Hidalgo Rodolfo

首页> 外文期刊>Journal of clinical rheumatology >INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING

【24h】

INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING

机译：在真实世界中使用阿达木单抗，依那西普或英夫昔单抗治疗的阿根廷类风湿关节炎患者中的抗药性抗体的发生率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of clinical rheumatology》 |2016年第3期|共1页
作者
Maid Pablo; Real Rosa; Pedersen Ron; Shen Qi; Hidalgo Rodolfo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING [J] . Maid Pablo, Real Rosa, Pedersen Ron, Journal of clinical rheumatology . 2016,第3期

机译：在真实世界中使用阿达木单抗，依那西普或英夫昔单抗治疗的阿根廷类风湿关节炎患者中的抗药性抗体的发生率
2. COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING [J] . Gokhale S. B., Cassel T., Mahon R., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：北欧地区英夫利昔单抗，依那西普和阿达木单抗治疗的类风湿关节炎患者的卫生保健费用比较
3. Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis [J] . Quistrebert Jocelyn, Hassler Signe, Bachelet Delphine, Seminars in Arthritis and Rheumatism . 2019,第6期

机译：类木单抗和英夫利昔单抗抗药物抗体中的发病率和危险因素在类风湿性关节炎中：欧洲回顾性多型型分析
4. Human Antichimeric Antibodies to Infliximab and Infusion-Related Allergic Reactions in Patients with Rheumatoid Arthritis [C] . D. Wouters, S. Stapel, M. Vis, Collegium Internationale Allergologicum . 2007

机译：人的苯甲酸纤维化率和类风湿性关节炎患者的infumency相关过敏反应的抗体抗体
5. The Efficacy of Therapeutic Drug Monitoring of Rheumatoid Arthritis Patients on Infliximab [D] . Abolhosn, Rania. 2018

机译：类风湿性关节炎患者治疗药物监测对英夫利昔单抗的疗效
6. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab etanercept or infliximab: Results from a multinational real-world clinical practice non-interventional study [O] . Robert J. Moots, Ricardo M. Xavier, Chi Chiu Mok, -1

机译：抗药物抗体对使用阿达木单抗依那西普或英夫利昔单抗治疗的类风湿关节炎患者的药物浓度和临床结局的影响：一项来自跨国现实世界的临床实践的非干预性研究结果
7. Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study [O] . Moots, RJ, Xavier, RM, Mok, CC, 2017

机译：校正：抗药物抗体对使用阿达木单抗，依那西普或英夫利昔单抗治疗的类风湿关节炎患者的药物浓度和临床结局的影响：一项来自跨国，真实世界的临床实践的非干预性研究结果

INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING

著录项

相似文献

相关主题

期刊订阅